These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 12433932)
1. NS-398 and piroxicam suppress UVB-induced activator protein 1 activity by mechanisms independent of cyclooxygenase-2. Liu G; Ma WY; Bode AM; Zhang Y; Dong Z J Biol Chem; 2003 Jan; 278(4):2124-30. PubMed ID: 12433932 [TBL] [Abstract][Full Text] [Related]
2. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin. Chun KS; Kim SH; Song YS; Surh YJ Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583 [TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 inhibitor (SC-236) suppresses activator protein-1 through c-Jun NH2-terminal kinase. Wong BC; Jiang XH; Lin MC; Tu SP; Cui JT; Jiang SH; Wong WM; Yuen MF; Lam SK; Kung HF Gastroenterology; 2004 Jan; 126(1):136-47. PubMed ID: 14699495 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism. Grau R; IƱiguez MA; Fresno M Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320 [TBL] [Abstract][Full Text] [Related]
5. Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms. Won YK; Ong CN; Shi X; Shen HM Carcinogenesis; 2004 Aug; 25(8):1449-58. PubMed ID: 15033901 [TBL] [Abstract][Full Text] [Related]
6. The MEK/ERK pathway mediates COX-2-selective NSAID-induced apoptosis and induced COX-2 protein expression in colorectal carcinoma cells. Elder DJ; Halton DE; Playle LC; Paraskeva C Int J Cancer; 2002 May; 99(3):323-7. PubMed ID: 11992399 [TBL] [Abstract][Full Text] [Related]
8. Piroxicam and NS-398 rescue neurones from hypoxia/reoxygenation damage by a mechanism independent of cyclo-oxygenase inhibition. Vartiainen N; Huang CY; Salminen A; Goldsteins G; Chan PH; Koistinaho J J Neurochem; 2001 Jan; 76(2):480-9. PubMed ID: 11208911 [TBL] [Abstract][Full Text] [Related]
9. Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells. Abiru S; Nakao K; Ichikawa T; Migita K; Shigeno M; Sakamoto M; Ishikawa H; Hamasaki K; Nakata K; Eguchi K Hepatology; 2002 May; 35(5):1117-24. PubMed ID: 11981761 [TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 inhibitor SC-236 [4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1-pyrazol-1-l] benzenesulfonamide] suppresses nuclear factor-kappaB activation and phosphorylation of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase, and c-Jun N-terminal kinase in human mast cell line cells. Kim SJ; Jeong HJ; Choi IY; Lee KM; Park RK; Hong SH; Kim HM J Pharmacol Exp Ther; 2005 Jul; 314(1):27-34. PubMed ID: 15784648 [TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 inhibitor NS-398 suppresses cell growth and constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells. Nakata H; Uemura Y; Kobayashi M; Harada R; Taguchi H Cancer Sci; 2003 Feb; 94(2):173-80. PubMed ID: 12708493 [TBL] [Abstract][Full Text] [Related]
12. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells. Han S; Inoue H; Flowers LC; Sidell N Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1. Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. Feng R; Lu Y; Bowman LL; Qian Y; Castranova V; Ding M J Biol Chem; 2005 Jul; 280(30):27888-95. PubMed ID: 15944151 [TBL] [Abstract][Full Text] [Related]
15. Rhein inhibits TPA-induced activator protein-1 activation and cell transformation by blocking the JNK-dependent pathway. Lin S; Li JJ; Fujii M; Hou DX Int J Oncol; 2003 Apr; 22(4):829-33. PubMed ID: 12632075 [TBL] [Abstract][Full Text] [Related]
16. The effects of cyclooxygenase 2 inhibitors on cartilage erosion and bone loss in a model of Mycobacterium tuberculosis-induced monoarticular arthritis in the rat. Gilroy DW; Tomlinson A; Greenslade K; Seed MP; Willoughby DA Inflammation; 1998 Oct; 22(5):509-19. PubMed ID: 9793797 [TBL] [Abstract][Full Text] [Related]
17. Role of constitutive cyclooxygenase-2 in prostaglandin-dependent secretion in mouse colon in vitro. MacNaughton WK; Cushing K J Pharmacol Exp Ther; 2000 May; 293(2):539-44. PubMed ID: 10773026 [TBL] [Abstract][Full Text] [Related]
18. Flavanones structure-related inhibition on TPA-induced tumor promotion through suppression of extracellular signal-regulated protein kinases: involvement of prostaglandin E2 in anti-promotive process. Ko CH; Shen SC; Lin HY; Hou WC; Lee WR; Yang LL; Chen YC J Cell Physiol; 2002 Oct; 193(1):93-102. PubMed ID: 12209884 [TBL] [Abstract][Full Text] [Related]
19. Curcumin inhibits the expression of COX-2 in UVB-irradiated human keratinocytes (HaCaT) by inhibiting activation of AP-1: p38 MAP kinase and JNK as potential upstream targets. Cho JW; Park K; Kweon GR; Jang BC; Baek WK; Suh MH; Kim CW; Lee KS; Suh SI Exp Mol Med; 2005 Jun; 37(3):186-92. PubMed ID: 16000872 [TBL] [Abstract][Full Text] [Related]
20. Dose-dependent modulation of apoptosis and cyclooxygenase-2 expression in human 1547 osteosarcoma cells by NS-398, a selective cyclooxygenase-2 inhibitor. Moalic S; Liagre B; Le Bail JC; Beneytout JL Int J Oncol; 2001 Mar; 18(3):533-40. PubMed ID: 11179483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]